Atlas Trials

Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal

Clinical trial NCT03751176 · UNKNOWN

Trial details

NCT number
NCT03751176
Sponsor
Grupo Espanol Multidisciplinario del Cancer Digestivo
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2018-11-08
Primary completion
2020-11-30
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.